Back
Results - Announcements
Sales rise 30.04% to Rs 33.16 crore
Godavari Drugs standalone net profit rises 44.94% in the March 2026 quarter
28-May-2026, 07:22
Net profit of Godavari Drugs rose 44.94% to Rs 1.29 crore in the quarter ended March 2026 as against Rs 0.89 crore during the previous quarter ended March 2025. Sales rose 30.04% to Rs 33.16 crore in the quarter ended March 2026 as against Rs 25.50 crore during the previous quarter ended March 2025.
Net profit of Godavari Drugs rose 44.94% to Rs 1.29 crore in the quarter ended March 2026 as against Rs 0.89 crore during the previous quarter ended March 2025. Sales rose 30.04% to Rs 33.16 crore in the quarter ended March 2026 as against Rs 25.50 crore during the previous quarter ended March 2025.
For the full year,net profit declined 6.62% to Rs 4.09 crore in the year ended March 2026 as against Rs 4.38 crore during the previous year ended March 2025. Sales declined 6.65% to Rs 105.81 crore in the year ended March 2026 as against Rs 113.35 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 33.16 | 25.50 | 30 | 105.81 | 113.35 | -7 |
| OPM % | 8.87 | 12.20 | - | 9.74 | 10.44 | - |
| PBDT | 2.13 | 2.11 | 1 | 7.13 | 8.08 | -12 |
| PBT | 1.52 | 1.44 | 6 | 4.70 | 5.63 | -17 |
| NP | 1.29 | 0.89 | 45 | 4.09 | 4.38 | -7 |
Powered by Capital Market - Live News